{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:43:07Z","timestamp":1791776587920,"version":"4.3.4"},"reference-count":32,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,2,15]]},"abstract":"<jats:p>This study describes a novel application of HLAMatchmaker to determine platelet compatibility in 16 alloimmunized patients with aplastic anemia refractory to random donor platelet transfusions. HLAMatchmaker is a software algorithm that predicts HLA compatibility by identifying immunogenic epitopes represented by amino acid triplets in antibody-accessible regions of human leukocyte antigen (HLA) molecules and determines the number of triplet mismatches (TMMs) and highly immunogenic triplet mismatches (HIMMs). Corrected count increments (CCIs) and molecular HLA typing were available for 523 transfusions. Conventional compatibility assessment based on cross-reactive group (CREG) determination was not predictive of transfusion outcome. Low HIMMs and TMMs numbers were associated with a higher likelihood of satisfactory (CCIs \u2265 8) compared with unsatisfactory (CCIs &lt; 8) outcomes (median HIMMs = 4 vs 6, p2 value &lt; .001; median TMMs = 11 vs 13, p2 value &lt; .001). Although receiver operator characteristic curves revealed that HIMMs or TMMs number are not powerful predictors of individual transfusion outcome, a threshold of at least 3 HIMMs or at least 9 TMMs appeared to be associated with successful transfusions. Triplet-matched transfusions were successful, regardless of CREG matching. Our data validate HLAMatchmaker for platelet transfusions and demonstrate its potential to refine and expand donor selection for HLA-alloimmunized patients.<\/jats:p>","DOI":"10.1182\/blood-2004-10-4080","type":"journal-article","created":{"date-parts":[[2005,11,4]],"date-time":"2005-11-04T01:48:52Z","timestamp":1131068932000},"page":"1680-1687","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":66,"title":["HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients"],"prefix":"10.1182","volume":"107","author":[{"given":"Ashok","family":"Nambiar","sequence":"first","affiliation":[{"name":"From the Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD; the Division of Transplantation Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA; and the Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene J.","family":"Duquesnoy","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD; the Division of Transplantation Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA; and the Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Adams","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD; the Division of Transplantation Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA; and the Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdong","family":"Zhao","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD; the Division of Transplantation Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA; and the Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Oblitas","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD; the Division of Transplantation Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA; and the Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Leitman","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD; the Division of Transplantation Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA; and the Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Stroncek","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD; the Division of Transplantation Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA; and the Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marincola","sequence":"additional","affiliation":[{"name":"From the Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD; the Division of Transplantation Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA; and the Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111905111171100_REF1","doi-asserted-by":"crossref","unstructured":"Santoso S, Kalb R, Kiefel V, Mueller-Eckhardt C. The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis. Br J Haematol. 1993;84: 451-456.","DOI":"10.1111\/j.1365-2141.1993.tb03100.x"},{"key":"2019111905111171100_REF2","doi-asserted-by":"crossref","unstructured":"Datema G, Stein S, Eijsink C, Mulder A, Class FH, Doxiadis II. HLA-C expression on platelets: studies with an HLA-Cw1-specific human monoclonal antibody. Vox Sang. 2000;79: 108-111.","DOI":"10.1046\/j.1423-0410.2000.7920108.x"},{"key":"2019111905111171100_REF3","unstructured":"McFarland JG. Alloimmunization and platelet transfusion. Semin Hematol. 1996;33: 315-328."},{"key":"2019111905111171100_REF4","doi-asserted-by":"crossref","unstructured":"Slichter SJ. Algorithm for managing the platelet refractory patient. J Clin Apheresis. 1997;12: 4-9.","DOI":"10.1002\/(SICI)1098-1101(1997)12:1<4::AID-JCA2>3.0.CO;2-E"},{"key":"2019111905111171100_REF5","doi-asserted-by":"crossref","unstructured":"Schiffer CA. Diagnosis and management of refractoriness to platelet transfusion. Blood Rev. 2001;15: 175-180.","DOI":"10.1054\/blre.2001.0164"},{"key":"2019111905111171100_REF6","doi-asserted-by":"crossref","unstructured":"Sacher RA, Kickler TS, Schiffer CA, Sherman LA, Bracey AW, Shulman IA. Management of patients refractory to platelet transfusion. Arch Pathol Lab Med. 2003;127: 409-414.","DOI":"10.5858\/2003-127-0409-MOPRTP"},{"key":"2019111905111171100_REF7","doi-asserted-by":"crossref","unstructured":"Duquesnoy RJ, Filip DJ, Ridey GE, Rumm AA, Aster RH. Successful transfusion of platelets \u201cmismatched\u201d for HLA antigens for alloimmunized, thrombocytopenic patients. Am J Hematol. 1997;2: 219-225.","DOI":"10.1002\/ajh.2830020303"},{"key":"2019111905111171100_REF8","doi-asserted-by":"crossref","unstructured":"McElligott MC, Menitove JE, Duquesnoy RJ, Hunter JB, Aster RH. Effect of HLA Bw4\/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients. Blood. 1982;59: 971-975.","DOI":"10.1182\/blood.V59.5.971.971"},{"key":"2019111905111171100_REF9","doi-asserted-by":"crossref","unstructured":"Schiffer CA, O'Connell B, Lee EJ. Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets. Blood. 1989;74: 1172-1176.","DOI":"10.1182\/blood.V74.3.1172.1172"},{"key":"2019111905111171100_REF10","doi-asserted-by":"crossref","unstructured":"Moroff G, Garratty G, Heal JM, et al. Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion. 1992;32: 633-640.","DOI":"10.1046\/j.1537-2995.1992.32792391036.x"},{"key":"2019111905111171100_","doi-asserted-by":"crossref","unstructured":"Kickler TS, Braine H, Ness PM. The predictive value of crossmatching platelet transfusion for alloimmunized patients. Transfusion. 1985;25: 385-389.","DOI":"10.1046\/j.1537-2995.1985.25485273823.x"},{"key":"2019111905111171100_","doi-asserted-by":"crossref","unstructured":"Sintnicolaas K, Lowenberg B. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions. Br J Haematol. 1996;92: 1005-1010.","DOI":"10.1046\/j.1365-2141.1996.414953.x"},{"key":"2019111905111171100_","doi-asserted-by":"crossref","unstructured":"Gelb AB, Leavitt AD. Crossmatch-compatible platelets improve correct count increments in patients who are refractory to randomly selected platelets. Transfusion. 1997;37: 624-630.","DOI":"10.1046\/j.1537-2995.1997.37697335157.x"},{"key":"2019111905111171100_REF14","doi-asserted-by":"crossref","unstructured":"Kekomaki S, Volin L, Koinstinen P, et al. Successful treatment of platelet transfusion refractoriness: the use of platelet transfusions matched for both human leukocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with leukemia. Eur J Haematol. 1998;60: 112-118.","DOI":"10.1111\/j.1600-0609.1998.tb01007.x"},{"key":"2019111905111171100_REF15","doi-asserted-by":"crossref","unstructured":"Duquesnoy RJ. HLA matchmaker: a molecularly based algorithm for histocompatibility determination, I: description of the algorithm. Hum Immunol. 2002; 63: 339-352.","DOI":"10.1016\/S0198-8859(02)00382-8"},{"key":"2019111905111171100_REF16","doi-asserted-by":"crossref","unstructured":"Duquesnoy RJ, Marrari M. HLA matchmaker: a molecularly based algorithm for histocompatibility determination, II: verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol. 2002;63: 353-363.","DOI":"10.1016\/S0198-8859(02)00381-6"},{"key":"2019111905111171100_REF17","doi-asserted-by":"crossref","unstructured":"Duquesnoy RJ, Takemoto S, de Lange P, et al. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination, III: effect of matching at the HLA-A, B amino acid triplet level on kidney transplant survival. Transplantation. 2003;75: 884-889.","DOI":"10.1097\/01.TP.0000055101.20821.AC"},{"key":"2019111905111171100_REF18","doi-asserted-by":"crossref","unstructured":"Daly PA, Schiffer CA, Aisner J, Wiernik PH. Platelet transfusion therapy: one-hour post-transfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA. 1980;243: 435-438.","DOI":"10.1001\/jama.1980.03300310023016"},{"key":"2019111905111171100_REF19","doi-asserted-by":"crossref","unstructured":"Davis KB, Slichter SJ, Corash L. Corrected count increment and percent platelet recovery as measures of post-transfusion platelet response: problems and a solution. Transfusion. 1999;39: 586-592.","DOI":"10.1046\/j.1537-2995.1999.39060586.x"},{"key":"2019111905111171100_REF20","doi-asserted-by":"crossref","unstructured":"Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992;39: 225-235.","DOI":"10.1111\/j.1399-0039.1992.tb01940.x"},{"key":"2019111905111171100_REF21","doi-asserted-by":"crossref","unstructured":"George SL, Gehan EA. Methods for measurement of body surface area. J Pediatr. 1979;94: 342-343.","DOI":"10.1016\/S0022-3476(79)80870-7"},{"key":"2019111905111171100_REF22","doi-asserted-by":"crossref","unstructured":"Dankers MK, Witvliet MD, Roelen DL, et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation. 2004;77: 1236-1239.","DOI":"10.1097\/01.TP.0000120385.03278.28"},{"key":"2019111905111171100_REF23","unstructured":"Duquesnoy RJ. HLAMatchmaker program. University of Pittsburgh Medical Center Transplant Pathology Internet Services web site. Available at: http:\/\/tpis.upmc.edu\/. Accessed on December 1, 2004."},{"key":"2019111905111171100_REF24","doi-asserted-by":"crossref","unstructured":"Schreuder GM, Hurley CK, Marsh SG, et al. The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1\/3\/4\/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Eur J Immunogenet. 2001;28: 565-596.","DOI":"10.1046\/j.0960-7420.2001.00284.x"},{"key":"2019111905111171100_REF25","doi-asserted-by":"crossref","unstructured":"Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240: 1285-1293.","DOI":"10.1126\/science.3287615"},{"key":"2019111905111171100_REF26","doi-asserted-by":"crossref","unstructured":"Lobashevsky AL, Senkbeil RW, Shoaf JL, et al. The number of amino acid residues mismatches correlated with flow cytometry crossmatching results in high PRA renal patients. Human Immunol. 2002;63: 364-374.","DOI":"10.1016\/S0198-8859(02)00371-3"},{"key":"2019111905111171100_REF27","doi-asserted-by":"crossref","unstructured":"Leach MF, AuBuchon JP. Effect of storage time on clinical efficacy of single-donor platelet units. Transfusion. 1993;33: 661-664.","DOI":"10.1046\/j.1537-2995.1993.33893342748.x"},{"key":"2019111905111171100_REF28","doi-asserted-by":"crossref","unstructured":"Norol F, Kuentz M, Cordonnier C, et al. Influence of clinical status on the efficiency of stored platelet transfusion. Br J Haematol. 1994;86: 125-129.","DOI":"10.1111\/j.1365-2141.1994.tb03262.x"},{"key":"2019111905111171100_REF29","doi-asserted-by":"crossref","unstructured":"Aster RH. Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood. 1965;26: 732-743.","DOI":"10.1182\/blood.V26.6.732.732"},{"key":"2019111905111171100_REF30","doi-asserted-by":"crossref","unstructured":"Cooling LL, Kelly K, Barton J, Hwang D, Koerner TA, Olson JD. Determinants of ABH expression on human blood platelets. Blood. 2005;105: 3356-3364.","DOI":"10.1182\/blood-2004-08-3080"},{"key":"2019111905111171100_REF31","doi-asserted-by":"crossref","unstructured":"Sintasath DM, Bei M, Steiner N, et al. Analysis of HLA-A and -B serologic typing of bone marrow registry donors using polymerase chain reaction with sequence-specific oligonucleotide probes and DNA sequencing. Tissue Antigens. 1997;50: 366-371.","DOI":"10.1111\/j.1399-0039.1997.tb02889.x"},{"key":"2019111905111171100_REF32","doi-asserted-by":"crossref","unstructured":"Adams SD, Barracchini KC, Chen D, et al. Ambiguous allele combinations in HLA class I and class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification. J Transl Med. 2004;2: 30.","DOI":"10.1186\/1479-5876-2-30"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/4\/1680\/468425\/zh800406001680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/4\/1680\/468425\/zh800406001680.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T05:34:49Z","timestamp":1626672889000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/4\/1680\/133652\/HLAMatchmakerdriven-analysis-of-responses-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,15]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-10-4080","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,15]]}}}